{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:36:23Z","timestamp":1792647383950,"version":"4.5.0"},"reference-count":55,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:00:00Z","timestamp":1703980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cystic Fibrosis Foundation, USA","award":["FNDR21W0-SC"],"award-info":[{"award-number":["FNDR21W0-SC"]}]},{"name":"Foundation for Neglected Disease Research, Bangalore, India","award":["FNDR21W0-SC"],"award-info":[{"award-number":["FNDR21W0-SC"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Non-tuberculous Mycobacteria (NTM), previously classified as environmental microbes, have emerged as opportunistic pathogens causing pulmonary infections in immunocompromised hosts. The formation of the biofilm empowers NTM pathogens to escape from the immune response and antibiotic action, leading to treatment failures. NF1001 is a novel thiopeptide antibiotic first-in-class compound with potent activity against planktonic\/replicating and biofilm forms of various NTM species. It is potent against both drug-sensitive and -resistant NTM. It has demonstrated a concentration-dependent killing of replicating and intracellularly growing NTM, and has inhibited and reduced the viability of NTM in biofilms. Combination studies using standard-of-care (SoC) drugs for NTM exhibited synergetic\/additive effects, but no antagonism against both planktonic and biofilm populations of Mycobacterium abscessus and Mycobacterium avium. In summary, the activity of NF1001 alone or in combination with SoC drugs projects NF1001 as a promising candidate for the treatment of difficult-to-treat NTM pulmonary diseases (NTM-PD) and cystic fibrosis (CF) in patients.<\/jats:p>","DOI":"10.3390\/pathogens13010040","type":"journal-article","created":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T06:00:21Z","timestamp":1704002421000},"page":"40","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Novel Inhibitor against the Biofilms of Non-Tuberculous Mycobacteria"],"prefix":"10.3390","volume":"13","author":[{"given":"Parvinder","family":"Kaur","sequence":"first","affiliation":[{"name":"Foundation for Neglected Disease Research (FNDR), Doddaballapur, Bengaluru 561203, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya Vadageri","family":"Krishnamurthy","sequence":"additional","affiliation":[{"name":"Foundation for Neglected Disease Research (FNDR), Doddaballapur, Bengaluru 561203, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-1340","authenticated-orcid":false,"given":"Radha Krishan","family":"Shandil","sequence":"additional","affiliation":[{"name":"Foundation for Neglected Disease Research (FNDR), Doddaballapur, Bengaluru 561203, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mohan","sequence":"additional","affiliation":[{"name":"National Center for Polar & Ocean Research (NCPOR), Headland Sada, Vasco da Gama 403802, Goa, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shridhar","family":"Narayanan","sequence":"additional","affiliation":[{"name":"Foundation for Neglected Disease Research (FNDR), Doddaballapur, Bengaluru 561203, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jinf.2015.12.007","article-title":"The antimicrobial susceptibility of non-tuberculous mycobacteria","volume":"72","author":"Cowman","year":"2016","journal-title":"J. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Narayanaswamy, V.P., Townsend, S.M., Loughran, A.J., Wiesmann, W., and Baker, S. (2022). Polycationic glycopolymer demonstrates activity against persisters and biofilms of non-tuberculosis mycobacteria cystic fibrosis clinical isolates in vitro. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.821820"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"809014","DOI":"10.1155\/2015\/809014","article-title":"General overview on nontuberculous mycobacteria, biofilms, and human infection","volume":"2015","author":"Faria","year":"2015","journal-title":"J. Pathogens."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2020.00303","article-title":"The rise of non-tuberculosis Mycobacterial lung disease","volume":"11","author":"Ratnatunga","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4046\/trd.2018.0026","article-title":"Infection source and epidemiology of nontuberculous mycobacterial lung disease","volume":"82","author":"Jeon","year":"2019","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijmyco.2014.11.065","article-title":"Nontuberculous mycobacteria pathogenesis and biofilm assembly","volume":"4","author":"Sousa","year":"2015","journal-title":"Int. J. Mycobacteriology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.drudis.2018.04.001","article-title":"NTM drug discovery: Status, gaps, and the way forward","volume":"23","author":"Wu","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"Prevots","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0035-1546751","article-title":"Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"36","author":"Park","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/thoraxjnl-2012-201772","article-title":"Chronic respiratory disease, inhaled corticosteroids, and risk of non-tuberculous mycobacteriosis","volume":"68","author":"Andrejak","year":"2013","journal-title":"Thorax"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tim.2009.12.007","article-title":"Mycobacterium abscessus: A new player in the mycobacterial field","volume":"18","author":"Medjahed","year":"2010","journal-title":"Trends Microbiol."},{"key":"ref_13","unstructured":"Cystic Fibrosis Foundation Patient Registry (2023, November 01). Annual Data Report. Cystic Fibrosis Foundation Publication. Available online: https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2020-12\/2010%20Registry%20Annual%20Data%20Report.pdf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.3346\/jkms.2022.37.e250","article-title":"The Higher Incidence of COVID-19 in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea","volume":"37","author":"Kim","year":"2022","journal-title":"J. Korean Med. Sci."},{"key":"ref_15","first-page":"413","article-title":"Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: Development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model. International","volume":"3","author":"Graciela","year":"2018","journal-title":"J. Med. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thorsurg.2018.09.008","article-title":"Nontuberculous mycobacterial infections in cystic fibrosis","volume":"29","author":"Martiniano","year":"2019","journal-title":"Thorac. Surg. Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2166\/wh.2003.0016","article-title":"Nontuberculous mycobacteria in hospital water systems: Application of HPLC for identification of environmental mycobacteria","volume":"1","author":"Galassi","year":"2003","journal-title":"J. Water Health"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cell.2005.11.011","article-title":"Mycobacterial biofilms: A greasy way to hold it together","volume":"123","author":"Zambrano","year":"2005","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijtb.2016.11.013","article-title":"Biofilm colonization of Mycobacterium abscessus: New threat in hospital-acquired surgical site infection","volume":"64","author":"Ghosh","year":"2017","journal-title":"Indian J. Tuberc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1121357","article-title":"Bacterial small-molecule signalling pathways","volume":"311","author":"Camilli","year":"2006","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13756-019-0533-3","article-title":"Antibiotics versus biofilm: An emerging battleground in microbial communities","volume":"8","author":"Sharma","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102338","DOI":"10.1016\/j.tube.2023.102338","article-title":"Colorado Mycobacteria Conference 2020: Focus on Nontuberculous Mycobacteria","volume":"140","author":"Ojha","year":"2023","journal-title":"Tuberculosis"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yam, Y.-K., Alvarez, N., Go, M.-L., and Dick, T. (2020). Extreme Drug Tolerance of Mycobacterium abscessus Persisters. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00359"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcf.2014.08.002","article-title":"Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia","volume":"14","author":"Qvist","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1164\/rccm.201508-1586IM","article-title":"Biofilm formation by Mycobacterium abscessus in a lung cavity","volume":"193","author":"Fennelly","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2307\/1537438","article-title":"Observations on the multiplication of bacteria in different volumes of stored seawater and the influence of oxygen tension and solid surfaces","volume":"7","author":"Zobell","year":"1936","journal-title":"Biol. Bull. Woods Hole"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3201\/eid2203.151643","article-title":"Leveraging advances in tuberculosis diagnosis and treatment to address nontuberculous mycobacterial disease","volume":"22","author":"Raju","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejim.2015.03.001","article-title":"Multidrug-resistant tuberculosis may be nontuberculous mycobacteria","volume":"26","author":"Shahraki","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"ref_29","unstructured":"IDSA (2023, November 01). The MAC Lung Damage Visualizer. Available online: https:\/\/www.ntmfacts.com\/treat\/#."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e0170421","DOI":"10.1128\/AAC.01704-21","article-title":"Potency of Omadacycline against Mycobacteroides abscessus clinical isolates in vitro and in a mouse model of pulmonary infection","volume":"66","author":"Nicklas","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lee, J.M., Park, J., Choi, S., Jhun, B.W., Kim, S.-Y., Jo, K.-W., Hong, J.J., Kim, L.-H., and Shin, S.J. (2021). A clofazimine-containing regimen confers improved treatment outcomes in macrophages and in a murine model of chronic progressive pulmonary infection caused by the Mycobacterium avium Complex. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.626216"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3201\/eid2703.202359","article-title":"Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV","volume":"27","author":"Gil","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mulyukin, A.L., Recchia, D., Kostrikina, N.A., Artyukhina, M.V., Martini, B.A., Stamilla, A., Degiacomi, G., and Salina, E.G. (2023). Distinct Effects of Moxifloxacin and Bedaquiline on Growing and \u2018Non-Culturable\u2019 Mycobacterium abscessus. Microorganisms, 11.","DOI":"10.3390\/microorganisms11112690"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Degiacomi, G., Sammartino, J.C., Chiarelli, L.R., Riabova, O., Makarov, V., and Pasca, M.R. (2019). Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235868"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kim, S.-Y., Shin, S.J., Jeong, B.-H., and Koh, W.-J. (2016). Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: Case report. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1554-7"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1801991","DOI":"10.1183\/13993003.01991-2018","article-title":"Mycobacterium abscessus pulmonary disease: Individual patient data meta-analysis","volume":"54","author":"Kwak","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_37","unstructured":"Narayanan, S., Kaur, P., Kumar, C.N.N., and Mohan, R. (2020). WO2020141478-Thiazolyl Peptides for the Treatment of Non-Tuberculous Mycobacterial Infections. (PCT\/IB2020\/050021), Patent."},{"key":"ref_38","unstructured":"CLSI\u2014Clinical and Laboratory Standards Institute (CLSI) (2019). Susceptibility Testing of Mycobacteria, Nocardia, and other Aerobic Actinomycetes, CLSI."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kaur, P., Ghosh, A., Krishnamurthy, R.V., Bhattacharjee, D.G., Achar, V., Datta, S., Shridhar, N., Anand, A., and Ramaiah, S. (2015). A High-Throughput Cidality Screen for Mycobacterium tuberculosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117577"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1021\/jm401382v","article-title":"Azaindoles: Noncovalent DprE1 inhibitors from scaffold morphing efforts kill Mycobacterium tuberculosis and are efficacious in vivo","volume":"56","author":"Shirude","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/AAC.47.7.2118-2124.2003","article-title":"Pharmacokinetic-pharmacodynamic relationships for rifampicin in an aerosol infection model of tuberculosis","volume":"47","author":"Jayaram","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1128\/AAC.00414-06","article-title":"Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis: Evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy","volume":"51","author":"Shandil","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_43","first-page":"e3820","article-title":"Growth of Mycobacterium tuberculosis Biofilms","volume":"60","author":"Kulka","year":"2012","journal-title":"J. Vis. Exp."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"102104","DOI":"10.1016\/j.tube.2021.102104","article-title":"A multi-targeting pre-clinical candidate against drug-resistant tuberculosis","volume":"129","author":"Kaur","year":"2021","journal-title":"Tuberculosis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/cjm-2022-0147","article-title":"Marine-derived antimicrobial molecules from the sponges and their associated bacteria","volume":"69","author":"Devkar","year":"2023","journal-title":"Can. J. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/md12010317","article-title":"Thiopeptide antibiotics: Retrospective and recent advances","volume":"12","author":"Albericio","year":"2014","journal-title":"Mar. Drugs"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zhang, J., Leifer, F., Rose, S., Chun, D.Y., Thaisz, J., Herr, T., Nashed, M., Joseph, J., Perkins, W.R., and DiPetrillo, K. (2018). Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake into Macrophages. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00915"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e01212-19","DOI":"10.1128\/AAC.01212-19","article-title":"Biofilms of Mycobacterium abscessus Complex Can Be Sensitized to Antibiotics by Disaggregation and Oxygenation","volume":"64","author":"Kolpen","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e02488-18","DOI":"10.1128\/AAC.02488-18","article-title":"Mycobacterium abscessus cells have altered antibiotic tolerance and surface glycolipids in artificial cystic fibrosis sputum medium","volume":"63","author":"Parks","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1513\/AnnalsATS.202003-222CME","article-title":"Summary for Clinicians: 2020 Clinical Practice Guideline Summary for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease","volume":"17","author":"Kurz","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/ajrccm.185.2.231","article-title":"Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center","volume":"185","author":"Aitken","year":"2012","journal-title":"Am. J. Resp. Crit. Care Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcf.2012.06.009","article-title":"Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations","volume":"12","author":"Catherinot","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ppul.20222","article-title":"Nontuberculous mycobacterial infection in young children with cystic fibrosis","volume":"40","author":"Esther","year":"2005","journal-title":"Pediatr. Pulmonol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1128\/JCM.43.7.3467-3470.2005","article-title":"Age-related prevalence, and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis","volume":"43","author":"Ferroni","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1183\/20734735.014718","article-title":"Staphylococcus aureus in cystic fibrosis: Problem bug or an innocent bystander?","volume":"14","author":"Hurley","year":"2018","journal-title":"Breathe"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/1\/40\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:45:12Z","timestamp":1760132712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/1\/40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,31]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["pathogens13010040"],"URL":"https:\/\/doi.org\/10.3390\/pathogens13010040","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,31]]}}}